BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Capimune 25mg capsules 0802020G0BFAAAC	Capimune	Ciclosporin	Malignant Disease and Immunosuppression	134
Methotrexate 10mg/0.4ml inj pre-filled disposable devices 0801030P0AAFNFN	Methotrexate	Methotrexate	Malignant Disease and Immunosuppression	129
Leuprorelin 1.88mg inj pre-filled syringes 0803042N0AAAGAG	Leuprorelin acetate	Leuprorelin acetate	Malignant Disease and Immunosuppression	121
Zlatal 20mg/0.8ml solution for injection pre-filled syringes 0801030P0BEAAFE	Zlatal	Methotrexate	Malignant Disease and Immunosuppression	118
Cyprostat 50mg tablets 0803042E0BBAAAA	Cyprostat	Cyproterone acetate	Malignant Disease and Immunosuppression	115
Somatuline Autogel 60mg/0.5ml inj pfs with safety system 0803043P0BBAEAE	Somatuline	Lanreotide	Malignant Disease and Immunosuppression	113
Modigraf 1mg granules for oral suspenion sachets 0802020T0BDABAW	Modigraf	Tacrolimus	Malignant Disease and Immunosuppression	112
Casodex 50mg tablets 0803042A0BBAAAA	Casodex	Bicalutamide	Malignant Disease and Immunosuppression	110
CellCept 1g/5ml oral suspension 0802010M0BBAEAJ	CellCept	Mycophenolate mofetil	Malignant Disease and Immunosuppression	110
Methotrexate 12.5mg/0.5ml inj pre-filled disposable devices 0801030P0AAFPFP	Methotrexate	Methotrexate	Malignant Disease and Immunosuppression	108
Octreotide 30mg inj vials 0803043N0AAAFAF	Octreotide acetate	Octreotide acetate	Malignant Disease and Immunosuppression	104
Degarelix 120mg inj vials 0803042R0AAABAB	Degarelix	Degarelix	Malignant Disease and Immunosuppression	100
Capsorin 100mg capsules 0802020G0BGAAAD	Capsorin	Ciclosporin	Malignant Disease and Immunosuppression	98
Fulvestrant 250mg/5ml inj pre-filled syringes 0803041AAAAAAAA	Fulvestrant	Fulvestrant	Malignant Disease and Immunosuppression	94
Zlatal 15mg/0.6ml solution for injection pre-filled syringes 0801030P0BEAGFK	Zlatal	Methotrexate	Malignant Disease and Immunosuppression	93
Octreotide 20mg inj vials 0803043N0AAAGAG	Octreotide acetate	Octreotide acetate	Malignant Disease and Immunosuppression	90
Capsorin 50mg capsules 0802020G0BGABAF	Capsorin	Ciclosporin	Malignant Disease and Immunosuppression	89
Octreotide 100micrograms/1ml inj pre-filled syringes 0803043N0AAAPAP	Octreotide acetate	Octreotide acetate	Malignant Disease and Immunosuppression	88
Megestrol 40mg tablets 0803020L0AAAAAA	Megestrol acetate	Megestrol acetate	Malignant Disease and Immunosuppression	87
Flutamide 250mg tablets 0803042H0AAAAAA	Flutamide	Flutamide	Malignant Disease and Immunosuppression	84
Capsorin 25mg capsules 0802020G0BGACAC	Capsorin	Ciclosporin	Malignant Disease and Immunosuppression	83
Methotrexate 22.5mg/0.9ml inj pre-filled disposable devices 0801030P0AAFTFT	Methotrexate	Methotrexate	Malignant Disease and Immunosuppression	83
Tacrolimus 5mg/5ml oral suspension 0802020T0AAALAL	Tacrolimus (Systemic)	Tacrolimus	Malignant Disease and Immunosuppression	81
Tamoxifen 40mg tablets 0803041S0AAACAC	Tamoxifen citrate	Tamoxifen citrate	Malignant Disease and Immunosuppression	80
Methotrexate 7.5mg/0.3ml inj pre-filled disposable devices 0801030P0AAFMFM	Methotrexate	Methotrexate	Malignant Disease and Immunosuppression	77

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.